Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.53

Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.53, versus $0.67 reported last year. Revenue for the quarter came in at $610 million, versus $561 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Super Micro Computer rises on AI server market optimism
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold